---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020229"
form_type: "8-K"
ticker: "PALX"
cik: "0001938569"
company_name: "Palomino Laboratories Inc."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:26:00.430476+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Palomino Labs adds $275K to private placement; total raised ~$9.76M

## Summary
- On Oct 24, 2025, Palomino sold 183,334 units at $1.50/unit for $275,001 gross proceeds.
- Each unit consists of one share of common stock and one warrant (exercise price $1.50, term 1 yr after trading start).
- Placement agent Laidlaw & Co. received 10% cash commission, 2% expense allowance, and 18,333 warrants at $1.80 (7-yr term).
- Combined with prior Oct 6 closing, total units sold: 6,504,017 for aggregate gross proceeds of ~$9.76 million.

## SEC filing metadata
- accession: 0001493152-25-020229
- form_type: 8-K
- ticker: PALX
- cik: 0001938569
- company_name: Palomino Laboratories Inc.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938569/000149315225020229/0001493152-25-020229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938569/000149315225020229/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020229
- JSON: https://secwatch.observer/filing/0001493152-25-020229.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020229.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.